Anti-CD19 CAR transduced T-cellsCytokine release syndrome leading to graft versus host disease: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1636卷 / 1期
关键词：
D O I：
10.1007/s40278-017-25588-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：28 / 28
相关论文
共 50 条
  • [41] Anti-CD19 CAR-T cell therapy for systemic Lupus Erythematosus in a mouse disease model
    Jin, Xuexiao
    Lu, Linrong
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [42] Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
    Efrat Luttwak
    David Hagin
    Chava Perry
    Ofir Wolach
    Gilad Itchaki
    Odelia Amit
    Yael Bar-On
    Tal Freund
    Sigi Kay
    Rinat Eshel
    Irit Avivi
    Ron Ram
    Bone Marrow Transplantation, 2021, 56 : 1031 - 1037
  • [43] F16-il2-fusion-proteinFever, Cytokine release syndrome and liver graft versus host disease: 4 case reports
    Reactions Weekly, 2016, 1590 (1) : 96 - 96
  • [44] Perforin Is Dispensable for Anti-CD19 CAR-T Cell Cytotoxicity but Contributes to CAR-T Cell Contraction and Regulates Host Inflammatory Response
    Ishii, Kazusa
    Chien, Christopher Daniel
    Erwin-Cohen, Rebecca
    Young, Howard A.
    Fry, Terry J.
    BLOOD, 2017, 130
  • [45] Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells
    Galli, Eugenio
    Sora, Federica
    Hohaus, Stefan
    Fresa, Alberto
    Pansini, Ilaria
    Autore, Francesco
    Metafuni, Elisabetta
    Innocenti, Idanna
    Limongiello, Maria Assunta
    Giammarco, Sabrina
    Laurenti, Luca
    Bacigalupo, Andrea
    Chiusolo, Patrizia
    De Stefano, Valerio
    Sica, Simona
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 86 - 94
  • [46] Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome
    Wickel, Jonathan
    Schnetzke, Ulf
    Sayer-Klink, Anne
    Rinke, Jenny
    Borie, Dominic
    Dudziak, Diana
    Hochhaus, Andreas
    Heger, Lukas
    Geis, Christian
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [47] Camrelizumab/immunosuppressantsAcute graft versus host disease, secondary haemophagocytic syndrome and lack of efficacy: 2 case reports
    Reactions Weekly, 2023, 1946 (1) : 139 - 139
  • [48] Covid-19-vaccineExacerbation of chronic graft versus host disease: 9 case reports
    Reactions Weekly, 2022, 1903 (1) : 134 - 134
  • [49] Clinical outcomes for anti-CD19 CAR T cell (CTL019) products not meeting commercial release specifications
    Chong, E. A.
    Levine, B. L.
    Schuster, S.
    CYTOTHERAPY, 2020, 22 (05) : S29 - S29
  • [50] Anti-CD19-CAR transduced T-cellsFever, pancytopenia and increased serum cytokines: case report
    Reactions Weekly, 2017, 1675 (1) : 31 - 31
12345